Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03156179 · ClinicalTrials.gov registry record

Study of Calcium Metabolism in Teenage Girls With Type 1 Diabetes

A clinical trial of Diabetes Mellitus, Type 1, sponsored by University of Rochester.

Completed
Registry status
22
Enrollment target
1
Study location

NCT03156179 is a study of Diabetes Mellitus, Type 1 that has completed, run by University of Rochester. The registered enrollment target is 22 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03156179, a study of Diabetes Mellitus, Type 1, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
22 participants
Enrollment target
1
Study location

Study Summary

The proposed pilot study will enroll 33 adolescent females with type 1 diabetes for the assessment of whole body calcium metabolism using dual stable calcium isotopes. This is the state of the art technique for assessing calcium metabolism in the body and has been used in both healthy and diseased pediatric populations.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST calcium isotope analysis

Study Locations (1)

New York

  • Univeristy of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2015-09-01
Est. Completion 2016-12-31

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT03156179

The ClinicalTrials.gov registry entry for NCT03156179 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (98% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention - of which calcium isotope analysis is the first listed.

NCT03156179 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03156179 about?

NCT03156179 is a clinical study titled "Study of Calcium Metabolism in Teenage Girls With Type 1 Diabetes". The proposed pilot study will enroll 33 adolescent females with type 1 diabetes for the assessment of whole body calcium metabolism using dual stable calcium isotopes. This is the state of the art technique for assessing calcium metabolism in the body and has been used in both healthy and diseased p...

What is the current status of trial NCT03156179?

This trial is currently completed. The enrollment target is 22 participants. The study started on 2015-09-01. Estimated completion is 2016-12-31.

What conditions does trial NCT03156179 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.

What interventions are being tested in trial NCT03156179?

The interventions under investigation include: calcium isotope analysis (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03156179?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03156179 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 1

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.